# FDA Inspection 1112244 - Dallas IVF - December 09, 2019

Source: https://www.keypedia.com/records/fda_inspections/dallas-ivf/eeb2b06c-8461-463b-989b-0940d7e41c27
Source feed: FDA_Inspections

> FDA Inspection 1112244 for Dallas IVF on December 09, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1112244
- Company Name: Dallas IVF
- Inspection Date: 2019-12-09
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1234907 - 2024-03-28](https://www.keypedia.com/records/fda_inspections/dallas-ivf/6ccb41e6-89c3-41ae-ad35-dc3f3b071e8f)
- [FDA Inspection 1234907 - 2024-03-28](https://www.keypedia.com/records/fda_inspections/dallas-ivf/78545a43-2699-4137-9417-f4ac1d0a67ed)
- [FDA Inspection 1020991 - 2017-07-11](https://www.keypedia.com/records/fda_inspections/dallas-ivf/76e81478-5ddc-4114-9bc0-ab6553a07232)
- [FDA Inspection 817417 - 2013-02-07](https://www.keypedia.com/records/fda_inspections/dallas-ivf/fb8a8cd7-5c67-4c62-b492-e35e911f29db)
- [FDA Inspection 667829 - 2010-06-17](https://www.keypedia.com/records/fda_inspections/dallas-ivf/e11f4a2e-0d81-4d24-b67c-1dea7e8cd417)

Company: https://www.keypedia.com/companies/dallas-ivf/636e12c2-9a7b-4073-ad78-59b91ace0017

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d